Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.83K Hold
304
﹤0.01% 210
2026
Q1
$4.11K Hold
304
﹤0.01% 214
2025
Q4
$3.79K Hold
304
﹤0.01% 231
2025
Q3
$3.01K Hold
304
﹤0.01% 213
2025
Q2
$2.71K Hold
304
﹤0.01% 198
2025
Q1
$3.79K Hold
304
﹤0.01% 182
2024
Q4
$3.79K Hold
304
﹤0.01% 197
2024
Q3
$3.53K Hold
304
﹤0.01% 223
2024
Q2
$3.23K Hold
304
﹤0.01% 226
2024
Q1
$3.63K Hold
304
﹤0.01% 211
2023
Q4
$3.29K Buy
+304
New +$2.91K ﹤0.01% 218

Other funds holding VTRS

Fairman Group's VTRS Position: Q2 2026 in Review

Fairman Group held its Viatris (VTRS) position steady in Q2 2026 at 304 shares worth $4.83K. The position accounts for ﹤0.01% of the portfolio, ranked #210.

Fairman Group first reported a position in VTRS in Q4 2023 and has held it in 11 quarters since. 1,030 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Fairman Group held 304 shares of Viatris worth $4.83K as of Q2 2026.
  • Fairman Group left its Viatris share count unchanged in Q2 2026.
  • Viatris made up ﹤0.01% of Fairman Group's portfolio in Q2 2026, its #210 holding.
  • Fairman Group first reported a position in Viatris in Q4 2023 and has held it in 11 quarters since.
  • 1,030 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Fairman Group's 13F filing for Q2 2026, filed 4 Aug 2026.